Thursday, May 9, 2013

• Dendreon Announces First Quarter 2013 ResultsBusiness Wire( (Thu, May 9)

Monday, May 6, 2013

• PROVENGE® (sipuleucel-T) Data Presented at An Annual Scientific Urology MeetingBusiness Wire( (Mon, May 6)

Wednesday, April 24, 2013

• Dendreon to Host Conference Call on May 9 to Announce First Quarter Financial ResultsBusiness Wire( (Wed, Apr 24)

Monday, March 18, 2013

• Dendreon Announces Securities Class Action SettlementBusiness Wire( (Mon, Mar 18)

Tuesday, March 12, 2013

• Dendreon Announces Webcast Presentation at ROTH ConferenceBusiness Wire( (Tue, Mar 12)

Friday, March 8, 2013

• Biotech Industry Looks to Benefit From FDA's New "Breakthrough" DesignationMarketwired( (Fri, Mar 8)

Thursday, March 7, 2013

• How Cancer Beats the Immune SystemAccesswire( (Thu, Mar 7)

Monday, February 25, 2013

• Dendreon Announces Fourth Quarter and 2012 Year End ResultsBusiness Wire( (Mon, Feb 25)

Wednesday, February 13, 2013

• New PROVENGE® (sipuleucel-T) Data to Be Presented at 2013 American Society of Clinical Oncology (ASCO) Genitourinary Cancers SymposiumBusiness Wire( (Wed, Feb 13)

Monday, February 4, 2013

• Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's SuccessMarketwired( (Mon, Feb 4)

Wednesday, January 30, 2013

• Dendreon to Host Conference Call on February 25 to Announce Fourth Quarter and Full Year 2012 Financial Results and Webcast Presentations at Upcoming ConferencesBusiness Wire( (Wed, Jan 30)

Wednesday, January 9, 2013

• Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013Marketwired( (Wed, Jan 9)

Monday, January 7, 2013

• Dendreon Announces Preliminary Fourth Quarter 2012 RevenuesBusiness Wire( (Mon, Jan 7)